ChunMing Lin - Icares Medicus Deputy General Manager-Engineering
| 6612 Stock | TWD 122.50 4.50 3.81% |
Insider
ChunMing Lin is Deputy General Manager-Engineering of Icares Medicus since 2017.
| Tenure | 7 years |
| Phone | 886 3 657 9530 |
| Web | https://www.icaresmedicus.com |
Icares Medicus Management Efficiency
The company has return on total asset (ROA) of 0.0835 % which means that it generated a profit of $0.0835 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1317 %, meaning that it generated $0.1317 on every $100 dollars invested by stockholders. Icares Medicus' management efficiency ratios could be used to measure how well Icares Medicus manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| C Huang | Quanta Computer | N/A | |
| Kris Ou | PChome Online | N/A | |
| KunHe Kuo | Emerging Display Technologies | N/A | |
| Xun Tseng | PChome Online | N/A | |
| Thomas Tsou | Quanta Computer | N/A | |
| Jimmy Chin | Quanta Computer | N/A | |
| Winnie Liu | Asustek Computer | N/A | |
| ChengChung Yu | Emerging Display Technologies | N/A | |
| TaiKuang Wang | Emerging Display Technologies | N/A | |
| ChuChia Lin | RiTdisplay Corp | N/A | |
| Yunling Tong | RiTdisplay Corp | N/A | |
| Bruce Wu | Quanta Computer | N/A | |
| KeQian Chuang | Quanta Computer | N/A | |
| Ted Chang | Quanta Computer | N/A | |
| Li Yeh | Phytohealth Corp | N/A | |
| J Wei | Quanta Computer | N/A | |
| Mike Yang | Quanta Computer | N/A | |
| Zhizhi Wu | RiTdisplay Corp | N/A | |
| Terrisa Chung | Quanta Computer | N/A | |
| Alan Chai | Quanta Computer | N/A | |
| Michelle Hsieh | Quanta Computer | N/A | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0835 |
Icares Medicus Leadership Team
Elected by the shareholders, the Icares Medicus' board of directors comprises two types of representatives: Icares Medicus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Icares. The board's role is to monitor Icares Medicus' management team and ensure that shareholders' interests are well served. Icares Medicus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Icares Medicus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| TanLi Chen, Group Chief Financial Officer, Head of Finance & Accounting | ||
| Danli Chen, Group Chief Financial Officer, Head of Finance & Accounting | ||
| YingZong Yan, Director | ||
| Jerry Tseng, Vice Chairman of the Board, Group Chief Research & Development Officer | ||
| Kaiyuan Tan, Independent Director | ||
| JhihYing Guo, Independent Director | ||
| William Lee, General Manager, Director | ||
| Robert Cummings, General Manager-Subsidiary | ||
| Hongxun Ding, Independent Director | ||
| IhHoung Loh, Chairman of the Board, Group Chief Executive Officer | ||
| WenChu Tseng, Vice Chairman of the Board, Group Chief Research & Development Officer | ||
| ChunMing Lin, Deputy General Manager-Engineering | ||
| Zhiying Guo, Independent Director | ||
| Carl Cummings, Pres Subsidiary |
Icares Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Icares Medicus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0835 | |||
| Profit Margin | 0.27 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 2.39 B | |||
| Shares Outstanding | 34.16 M | |||
| Shares Owned By Insiders | 54.23 % | |||
| Shares Owned By Institutions | 0.28 % | |||
| Price To Earning | 59.67 X | |||
| Price To Book | 3.25 X |
Pair Trading with Icares Medicus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Icares Medicus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icares Medicus will appreciate offsetting losses from the drop in the long position's value.Moving together with Icares Stock
Moving against Icares Stock
| 0.7 | 5312 | Formosa Optical Tech | PairCorr |
| 0.69 | 1565 | StShine Optical | PairCorr |
| 0.64 | 4111 | Chi Sheng Chemical | PairCorr |
| 0.62 | 2603 | Evergreen Marine Corp | PairCorr |
| 0.59 | 2609 | Yang Ming Marine | PairCorr |
The ability to find closely correlated positions to Icares Medicus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Icares Medicus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Icares Medicus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Icares Medicus to buy it.
The correlation of Icares Medicus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Icares Medicus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Icares Medicus moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Icares Medicus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Icares Stock Analysis
When running Icares Medicus' price analysis, check to measure Icares Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icares Medicus is operating at the current time. Most of Icares Medicus' value examination focuses on studying past and present price action to predict the probability of Icares Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icares Medicus' price. Additionally, you may evaluate how the addition of Icares Medicus to your portfolios can decrease your overall portfolio volatility.